07.01.2013 Views

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

[Abstract Title]. - Society for Neuroscience

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Title</strong>: A novel free radical scavenger:platinum nanoparticle improves neurological signs and<br />

electrophisiological findings in a rat EAE model via quenching ROS and NO<br />

Authors: *H. YOSHIDA, M. SAGIC, J. SCHWERMAN, K. J. SMITH;<br />

Neuroinflammation, Neurol, Univ. Coll London, London, United Kingdom<br />

<strong>Abstract</strong>: Platinum nanoparticles were prepared by an alcohol reduction method and<br />

complementarily stabilized with polyacrilic acid(PAA-Pt). The average diameter of PAA-Pt was<br />

about 2nm. They were well dispersed in water and became colloidal solution. PAA-Pt efficiently<br />

quenched superoxide anion(O(2)(-)), Hydrogen peroxide(H(2)O(2))and Nitric oxicide(NO). This<br />

quenching activity against ROS and NO persisited like catalysis such as SOD or catalase.<br />

There<strong>for</strong>e, PAA-Pt may be a useful scavenger which is effective on medical treatment of<br />

oxidative stress diseases. In fact, we have shown that platinum nanoparticles are effective on<br />

animal models of various ROS-related diseases like stroke, Alzheimer's disease, Huntinton<br />

disease and so on. And this time, we evaluated the effect of PAA-Pt on experimental<br />

autoimmune encephalomyelitis(EAE) using a rat. Intravenous injection of PAA-Pt improves<br />

neurological signs and electrophysiological findings in an EAE rat model.<br />

Disclosures: H. Yoshida, None; M. Sagic, None; J. Schwerman, None; K.J. Smith, None.<br />

Poster<br />

252. Demyelinating Disorders: Mechanisms and Therapeutics II<br />

Time: Sunday, November 16, 2008, 1:00 pm - 5:00 pm<br />

Program#/Poster#: 252.9/W33<br />

Topic: C.08.d. Therapeutic strategies<br />

Support: National Multiple Sclerosis <strong>Society</strong> PP1247<br />

<strong>Title</strong>: Potential experimental therapy to improve Multiple Sclerosis (MS) symptoms in an animal<br />

model<br />

Authors: P. K. BOSE 1,3 , J. HOU 3 , *C. PHADKE 4 , R. SMITH 3 , R. PARMER 3 , Y. CHENG 3 , P.<br />

M. HOFFMAN 2 , W. STREIT 3 , F. J. THOMPSON 3 ;<br />

1 BRRC, 2 Res. Service, North Florida/South Georgia VAMC, Gainesville, FL; 3 Neurosci., Univ.<br />

of Florida, McKnight Brain Inst., Gainesville, FL; 4 Univ. Florida, Gainesville, FL<br />

<strong>Abstract</strong>: Symptoms and disabilities of MS appear across a broad spectrum, including spasticity,<br />

weakness, cognitive impairment, and balance disorder. Our recent Experimental Autoimmune<br />

Encephalomyelitis (EAE) rat model has revealed significant neurophysiological, locomotor,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!